financetom
Business
financetom
/
Business
/
Zurn Elkay Water Solutions Insider Sold Shares Worth $855,105, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zurn Elkay Water Solutions Insider Sold Shares Worth $855,105, According to a Recent SEC Filing
Nov 10, 2025 3:23 PM

05:52 PM EST, 11/10/2025 (MT Newswires) -- Timothy J Jahnke, Director, on November 07, 2025, sold 18,000 shares in Zurn Elkay Water Solutions ( ZWS ) for $855,105. Following the Form 4 filing with the SEC, Jahnke has control over a total of 468,864 common shares of the company, with 306,864 shares held directly and 162,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1439288/000143928825000170/xslF345X05/wk-form4_1762814814.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EcoSynthetix May Buy Back Up To Near 10% of Its Outstanding Shares
EcoSynthetix May Buy Back Up To Near 10% of Its Outstanding Shares
May 13, 2024
08:45 AM EDT, 05/13/2024 (MT Newswires) -- EcoSynthetix ( ECSNF ) on Monday said it intends to commence a normal course issuer bid. The renewable chemicals company may repurchase up to a maximum of near 4 million shares, or 10% of its outstanding shares, from May 15, 2024, for one year. Under its previous bid, which expired on May 1,...
Market Chatter: Novo Nordisk Plans First Bond Sale in 2 Years
Market Chatter: Novo Nordisk Plans First Bond Sale in 2 Years
May 13, 2024
08:47 AM EDT, 05/13/2024 (MT Newswires) -- Novo Nordisk A/S ( NVO ) , through its finance subsidiary in the Netherlands, has hired banks to help it issue euro-nominated bonds in a benchmark offering with 2- to 10-year maturities, Bloomberg reported, citing a person familiar with the matter. Proceeds would be used for general corporate purposes, including financing its Catalent...
Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment
Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment
May 13, 2024
08:45 AM EDT, 05/13/2024 (MT Newswires) -- Fulcrum Therapeutics ( FULC ) said Monday it has signed a deal with Sanofi ( SNY ) for losmapimod in treating facioscapulohumeral muscular dystrophy (FSHD). Under the terms of the deal, Sanofi ( SNY ) will have exclusive rights to commercialize losmapimod outside the US, while Fulcrum retains US rights, Fulcrum said. The...
Booking Designated as a Gatekeeper Under EU Digital Markets Act
Booking Designated as a Gatekeeper Under EU Digital Markets Act
May 13, 2024
08:46 AM EDT, 05/13/2024 (MT Newswires) -- Booking Holdings ( BKNG ) has been designated by the European Commission as a gatekeeper under the Digital Markets Act (DMA), the Commission said Monday. As a result, Booking has six months to submit a detailed compliance report outlining how it complies with each of the DMA's obligations, the Commission said. If Booking...
Copyright 2023-2026 - www.financetom.com All Rights Reserved